Michelle A. Hodges - Jan 31, 2025 Form 4 Insider Report for QuidelOrtho Corp (QDEL)

Role
Chief Legal Officer
Signature
/s/ Jennifer Ahn, attorney-in-fact for Michelle A. Hodges
Stock symbol
QDEL
Transactions as of
Jan 31, 2025
Transactions value $
-$67,276
Form type
4
Date filed
2/4/2025, 04:17 PM
Previous filing
Jan 31, 2025
Next filing
Feb 11, 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction QDEL Common Stock Award $0 +1.61K +9.37% $0.00 18.8K Jan 31, 2025 Direct F1, F2
transaction QDEL Common Stock Tax liability -$28.8K -662 -3.52% $43.46 18.1K Jan 31, 2025 Direct F3
transaction QDEL Common Stock Award $0 +1.81K +10.01% $0.00 19.9K Jan 31, 2025 Direct F1
transaction QDEL Common Stock Tax liability -$31.2K -717 -3.6% $43.46 19.2K Jan 31, 2025 Direct F3
transaction QDEL Common Stock Award $0 +474 +2.47% $0.00 19.7K Feb 1, 2025 Direct F1
transaction QDEL Common Stock Tax liability -$7.34K -169 -0.86% $43.46 19.5K Feb 1, 2025 Direct F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction QDEL Restricted Stock Units Options Exercise $0 -1.61K -50% $0.00 1.61K Jan 31, 2025 Common Stock 1.61K Direct F4, F5
transaction QDEL Restricted Stock Units Options Exercise $0 -1.81K -50% $0.00 1.81K Jan 31, 2025 Common Stock 1.81K Direct F4, F6
transaction QDEL Restricted Stock Units Options Exercise $0 -474 -100% $0.00 0 Feb 1, 2025 Common Stock 474 Direct F4, F7
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reflects release of restricted units that were previously reported on a Form 4.
F2 The amount of shares beneficially owned following this transaction includes an additional 512 shares due to the Reporting Person's purchase of shares pursuant to the Issuer's Employee Stock Purchase Plan.
F3 Disposition of shares, as set forth above, was in connection with the Issuer's withholding of common shares to satisfy tax withholding obligations related to the issuance of common shares upon release of restricted stock units.
F4 Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock.
F5 1,610 shares vested on January 31, 2025; the remaining 1,610 shares will vest on January 31, 2026.
F6 1,814 shares vested on January 31, 2025; the remaining 1,814 shares will vest on January 31, 2026.
F7 474 shares vested on January 31, 2025.